STAMPs at the crossroads of cancer and nutrition

Nutrition and Cancer

Volumn 62, Issue 7, 2010, Pages 891-895

  Lindstad, Torstein ^a   Jin, Yang ^a   Wang, Ling ^a   Qu, Su ^a   Saatcioglu, Fahri ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

6 TRANSMEMBRANE PROTEIN OF PROSTATE 1; 6 TRANSMEMBRANE PROTEIN OF PROSTATE 2; 6 TRANSMEMBRANE PROTEIN OF PROSTATE 3; ANDROGEN; MEMBRANE PROTEIN; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; STEAP1 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL PROLIFERATION; GENE IDENTIFICATION; HUMAN; METABOLIC SYNDROME X; NONHUMAN; NUTRITION; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TUMOR GENE;

ANIMALS; ANTIGENS, NEOPLASM; HUMANS; MALE; MEMBRANE PROTEINS; MICE; NEOPLASM PROTEINS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OXIDOREDUCTASES; PROSTATIC NEOPLASMS;

EID: 77957992690     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.509836     Document Type: Review

References (35)

1. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, et al.: Human prostate cancer risk factors. Cancer 101, 2371-2490, 2004.
2. Calle EE and Kaaks R: Overweight, obesity, and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4, 579-591, 2004.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al.: Cancer statistics, 2009. CA Cancer J Clin 59, 225-249, 2009.
4. Lin DW: Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Urol Oncol 27, 315-321, 2009.
5. Parekh DJ, Ankerst DP, and Thompson IM: Prostate-specific antigen levels, prostate-specific antigen kinetics, and prostate cancer prognosis: a tocsin calling for prospective studies. J Natl Cancer Inst 99, 496-497, 2007.
6. Brawley OW, Ankerst DP, and Thompson IM: Screening for prostate cancer. CA Cancer J Clin 59, 264-273, 2009.
7. Korkmaz CG, Korkmaz KS, Kurys P, Elbi C, Wang L, et al.: Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene 24, 4934-4945, 2005.
8. Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, et al.: Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem 277, 36689-36696, 2002.
9. Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, et al.: The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA 100, 2284-2289, 2003.
10. Heinlein CA and Chang C: Androgen receptor in prostate cancer. Endocr Rev 25, 276-308, 2004.
11. Korkmaz KS, Korkmaz CG, Ragnhildstveit E, Pretlow TG, and Saatcioglu F: An efficient procedure for cloning hormone-responsive genes from a specific tissue. DNA Cell Biol 19, 499-506, 2000.
12. Porkka KP, Helenius MA, and Visakorpi T: Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate. Lab Invest 82, 1573-1582, 2002.
13. Moldes M, Lasnier F, Gauthereau X, Klein C, Pairault J, et al.: Tumor necrosis factor-alpha-induced adipose-related protein (TIARP), a cell-surface protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J Biol Chem 276, 33938-33946, 2001.
14. Steiner MS, Zhang X, Wang Y, and Lu Y: Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res 60, 4419-4425, 2000.
15. Ohgami RS, Campagna DR, McDonald A, and Fleming MD: The Steap proteins are metalloreductases. Blood 108, 1388-1394, 2006.
16. Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, et al.: Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet 37, 1264-1269, 2005.
17. Sanchez-Pulido L, Rojas AM, Valencia A, Martinez AC, and Andrade MA: ACRATA: a novel electron transfer domain associated to apoptosis and cancer. BMC Cancer 4, 98, 2004.
18. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, et al.: Interleukin-6 is a positive regulator of tumor necrosis factor alpha-induced adiposerelated protein in 3T3-L1 adipocytes. FEBS Lett 560, 153-157.
19. Chambaut-Guerin AM and Pairault J: Tumor necrosis factor alpha-induced adipose-related protein (TIARP): co-localization with caveolin-1. Biol Cell 97, 339-347, 2005.
20. Amzallag N, Passer BJ, Allanic D, Segura E, Thery C, et al.: TSAP6 facilitates the secretion of translationally controlled tumor protein/histaminereleasing factor via a nonclassical pathway. J Biol Chem 279, 46104-46112, 2004.
21. Zhang X, Steiner MS, Rinaldy A, and Lu Y: Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3. Oncogene 20, 5982-5990, 2001.
22. Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA 96, 14523-14528, 1999.
23. Alves, PM, Faure O, Graff-Dubois S, Cornet S, Bolonakis I, et al.: STEAP, a prostate tumor antigen, is a target of human CD8+ T cells. Cancer Immunol Immunother 55, 1515-1523.
24. Garcia-Hernandez Mde L, Gray A, Hubby B, and Kast WM: In vivo effects of vaccination with six-transmembrane epithelial antigen of the prostate: a candidate antigen for treating prostate cancer. Cancer Res 67, 1344-1351, 2007.
25. Valenti MT, Dalle Carbonare L, Donatelli L, Bertoldo F, Giovanazzi B, et al.: STEAP mRNA detection in serum of patients with solid tumors. Cancer Lett 273, 122-126, 2009.
26. Xu H and Hotamisligil GS: Signaling pathways utilized by tumor necrosis factor receptor 1 in adipocytes to suppress differentiation. FEBS Lett 506, 97-102, 2001.
27. Fasshauer M, Klein J, Krahlisch S, Lossner U, Klier M, et al.: GH is a positive regulator of tumor necrosis factor alpha-induced adipose related protein in 3T3-L1 adipocytes. J Endocrinol 178, 523-531, 2003.
28. Kralisch S, Sommer G, Weise S, Lipfert J, Lossner U, et al.: Interleukin-1beta isapositive regulator of TIARP/STAMP2 gene and protein expression in adipocytes in vitro. FEBS Lett 583, 1196-1200, 2009.
29. Wellen KE, Fucho R, Gregor MF, Furuhashi M, Morgan C, et al.: Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell 129, 537-548, 2007.
30. Despres JP and Lemieux I: Abdominal obesity and metabolic syndrome. Nature 444, 881-887, 2006.
31. Hotamisligil GS: Inflammation and metabolic disorders. Nature 444, 860-867, 2006.
32. Wellen KE and Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 115, 1111-1119, 2005.
33. Arner P, Stenson BM, Dungner E, Naslund E, Hoffstedt J, et al.: Expression of six transmembrane protein of prostate 2 in human adipose tissue associates with adiposity and insulin resistance. J Clin Endocrinol Metab 93, 2249-2254.
34. Zhang CM, Chi X, Wang B, Zhang M, Ni YH, et al.: Downregulation of STEAP4, a highly-expressed TNF-alpha-inducible gene in adipose tissue, is associated with obesity in humans. Acta Pharmacol Sin 29, 587-592, 2008.
35. Hotamisligil GS and Erbay E: Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 8, 923-934, 2008.